M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Additional Paid In Capital Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Additional Paid In Capital
$610m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Additional Paid In Capital
$1.2B
CAGR 3-Years
6%
CAGR 5-Years
21%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Additional Paid In Capital
CHf476.1m
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Additional Paid In Capital
$3.3B
CAGR 3-Years
8%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Additional Paid In Capital
CHf367.5m
CAGR 3-Years
1%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Additional Paid In Capital?
Additional Paid In Capital
610m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Additional Paid In Capital amounts to 610m USD.

What is MoonLake Immunotherapeutics's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 1Y
372%

Over the last year, the Additional Paid In Capital growth was 372%.

Back to Top